Peer Review History

Original SubmissionFebruary 22, 2023
Decision Letter - Nina R. Salama, Editor, Sophie Helaine, Editor
Transfer Alert

This paper was transferred from another journal. As a result, its full editorial history (including decision letters, peer reviews and author responses) may not be present.

Dear Ms. Saleh,

Thank you very much for submitting your manuscript "SPI-1 virulence gene expression modulates motility of Salmonella Typhimurium in a proton motive force- and adhesins-dependent manner" for consideration at PLOS Pathogens. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. In light of the reviews (below this email), we would like to invite the resubmission of a significantly-revised version that takes into account the reviewers' comments.

We cannot make any decision about publication until we have seen the revised manuscript and your response to the reviewers' comments. Your revised manuscript is also likely to be sent to reviewers for further evaluation.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out.

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Please prepare and submit your revised manuscript within 60 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email. Please note that revised manuscripts received after the 60-day due date may require evaluation and peer review similar to newly submitted manuscripts.

Thank you again for your submission. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Sophie Helaine

Academic Editor

PLOS Pathogens

Nina Salama

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************

Reviewer's Responses to Questions

Part I - Summary

Please use this section to discuss strengths/weaknesses of study, novelty/significance, general execution and scholarship.

Reviewer #1: The manuscript by Saleh et al explores the effects of HilD activation on motility, stringent response and adhesin production in Salmonella Typhimurium. Specifically, they show that despite its role in activation of flhD expression, HilD overexpression reduces motility and increases the expression of several previously described adhesin gene clusters. The authors further tie this phenotype to SPI-1-dependent induction of the stringent response and decrease of PMF. The experiments are elegant, the data is convincing and the setups are well-described. Furthermore, the work touches upon an interesting topic of how certain transcriptional programs in S. Typhimurium can dissipate the cellular energy pool, ultimately leading to phenotypic changes. I have only spotted a few points that the authors might want to consider prior to publication.

Reviewer #2: Saleh et al. conclude that induction of the SPI1 T3SS leads to a loss of PMF and hence, loss of motility. Various adhesins are also induced. The overall data support the conclusion. This leads to an intriguing model in which the cell turns on SPI1 and stops swimming, potentially enhancing invasion. The issue is that this model is counter to the coordinate transcriptional induction of the two systems, a point that needs to be more fully discussed.

Reviewer #3: In this manuscript, Saleh and colleagues describe the effect of overexpression of HilD, the master transcriptional activator of the Salmonella SPI-1 injectisome, on bacterial cell physiology, especially motility. This study follows up on an earlier study by the same group (Singer et al., J Bact 2014), where HilD overexpression led to increased transcription of flhDC, the master transcription activator of the flagellum. In apparent contrast, the current study shows a strong reduction of motility upon HilD overexpression, which depends on the presence of SPI-1. Overexpression of HilD in presence of SPI-1 also resulted in an activation of the stringent response and reduced membrane potential. The authors propose that these data indicate a strategy to quickly change the bacterial lifestyle from mobile to adhesive upon contact to host cells.

The interplay of different molecular mechanisms (such as motility and protein secretion) is an important and so far poorly understood aspect of bacterial virulence. This manuscript addresses it with a wide range of experiments, which are presented in a clear and very attractive manner. Similarly, the proposed model is intuitive. However, the data mainly describe effects of overexpression of a known transcription factor, HilD, and confirm that these effects depend on the presence of its known main target, the SPI-1 injectisome. Whether and to which extent the results show a biologically relevant mechanism therefore remains largely unclear. Further, the reason for the – at least on the first look – clear discrepancy between the results of the 2014 paper and this manuscript is not revealed.

**********

Part II – Major Issues: Key Experiments Required for Acceptance

Please use this section to detail the key new experiments or modifications of existing experiments that should be absolutely required to validate study conclusions.

Generally, there should be no more than 3 such required experiments or major modifications for a "Major Revision" recommendation. If more than 3 experiments are necessary to validate the study conclusions, then you are encouraged to recommend "Reject".

Reviewer #1: 1. Although overexpression of HilD results in a set of well described and convincing phenotypes, I wonder if the authors may want to discuss how these phenotypes might change, if experiments had been performed under more physiologically relevant conditions. Using LB with 0.3M NaCl might be one option. It should be discussed if that accumulation of HilD and concomitant overexpression of type 3 secretion systems in the presented experiments might result not only affect the normal hilD regulon, but also yield some unspecific response phenotypes (Fig. S2B, differential expression of ca 1600 genes doesn’t look hilD-specific anymore). Could this be approached by comparing the published transcriptome data of hilD mutants vs wt (Colgan et al) side by side with the new data on inducible hilD expression?

2. The authors cite literature showing the roles of PMF not only in flagellar rotation, but also in flagellar synthesis (lines 334-335). They additionally link the induction of stringent response upon HilD overexpression to PMF dissipation (Figure 6). However, I am not sure why the flagellation level of such cells remained largely unaffected (Figure 5). Can the authors comment on that?

3. Figure 7: the model proposed by the authors relies on the assumption that HilD is only activated (resulting in repressed motility) upon the contact between STm and epithelial cells. However, it has been previously shown that HilD is activated by several environmental cues in the gut lumen (Ellermeier et al, 2008; Golubeva et al, 2012; Diard et al, 2013). I would say that the lines 419-430 are indeed highly speculative and not backed up by corresponding data. The authors may want to modify this statement.

Reviewer #2: None

Reviewer #3: 1. Almost all experiments were performed with strains overexpressing HilD (usually in wild-type and SPI-1 deletion backgrounds). A direct comparison of wild type and SPI-1 deletion without the overexpression of HilD would often have been possible and more physiologically relevant. Although overexpression of a transcriptional activator can yield insights into its working mechanism, interpretation of physiological effects of native expression of the target genes are difficult. The fact that strong overexpression of HilD and in turn the SPI-1 injectisome (a large membrane-spanning complex), leads to effects including loss of membrane potential, does not necessarily allow conclusions about the native interaction of SPI-1 expression and motility, as claimed in the title and throughout the manuscript. These claims should therefore be corrected.

2. The reason for the apparent contradiction between the results of Singer et al. (overexpression of HilD leads to increased transcription of flhDC) and this manuscript is a critical question, but remains unclear. The manuscript almost actively steers clear from data that would allow to clarify this point. For example, the transcriptomics data shown in Figure 2A for “selected genes” only includes two flagellar genes. To evaluate the data and any differences between the two studies (and potential reasons), the complete dataset must be made available, which can be done using a preliminary protected link for the reviewers. In addition, at least the genes presented in Figure 2A plus all flagellar genes must be listed with their names and the actual data in a Supplementary Table. Furthermore, it would be very helpful to show the protein levels of at least some flagellar components.

3. The abstract states that “overproduction of several adhesion systems phenocopied the HilD-induced motility defect”. While this is true for swimming velocities in a glass flow chamber (which, as the authors themselves state, is probably an artifact of attachment to the glass surface), this does not seem to be the case for the other observed phenotypes. Relatedly, the following sentence states that “combination of SPI-1-dependent depletion of the PMF and upregulation of adhesins (…) allows flagellated Salmonella to rapidly modulate their motility.” Given that deletion of SPI-1 alone rescues most phenotypes, it appears to be the main (or only) factor for them and the role of adhesins minor, if present at all.

4. Is it really that surprising to find that flagella and SPI-1 injectisomes are adversely regulated in Salmonella? Similar mutually negative regulation has been found in several other cases, including E. coli, Yersinia enterocolitica and Pseudomonas aeruginosa (Iyoda et al, J Bact (2006); Bleves et al, J Bact (2002); Soscia et al. J Bact (2007)). These references should be discussed and the text adapted accordingly.

**********

Part III – Minor Issues: Editorial and Data Presentation Modifications

Please use this section for editorial suggestions as well as relatively minor modifications of existing data that would enhance clarity.

Reviewer #1: 1. Line 268: It would be interesting to compare the growth rate and cell length phenotypes of hilD expression to the published data from Arnoldini et al 2014 and Hockenberry et al. 2021.

2. Lines 312-320: Authors rule out the potential role of RflP in the observed motility phenotype. However, in contrast to the quantification data, the microscopy image suggests a difference. The authors may want to choose a more representative image?

3. Line 56: no need for comma after “although”

4. Line 149: “exclude”, not “exclude for”

5. Statistical test results should be added in Fig. 1, Fig. 2BD, Fig. 3A

6. Fig. 2DE. It would be interesting for the readers, if the authors could discuss the differences in the two motility phenotypes of pcsg, psaf and pstd.

7. Line 337-343: The authors may want to discuss that besides T3SS effector secretion, errors or normal steps of T3SS apparatus assembly may also dissipate the PMF.

8. References 65 and 73 appear to be partially deleted?

Reviewer #2: 1. Line 79. “A battery of DNA-binding proteins, such as … HilD, HilC, and RtsA…” While numerous regulatory systems affect expression of SPI1, most function indirectly. This sentence makes HilD seem like a minor player.

2. Line 82. A pet peeve. I think calling HilA and an “OmpR/ToxR-type transcriptional regulator” can be confusing. The uninitiated might think it is a two-component regulator. It is only the DNA binding domain that is similar to OmpR.

3. The regulatory interplay between flagella and SPI1 is obviously complicated. You could use a model slide to make it clear.

4. Line 137. The strain description is not clear. “…a chromosomal copy of hilD under the control of an inducible promoter, including an ectopic locus (araBAD) and the native locus.” Is the “native locus” a tet promoter? Clarify. You also should point out that the native locus is intact in the ara:hilD strain.

5. Line 145. You do not describe the strain ectopically expressing hilA.

6. Fig 2B. You need statistical analyses. Is any of this significant?

7. Line 195. “Strains expressing hilD under the native promoter and deleted for SPI1…” This makes no sense. If SPI1 is deleted, so is hilD. This strain is ara::hilD, correct?

8. Line 231. Deletion of SPI1 blocks the effect. In your strains, deletion of SPI1 is likely to significantly decrease the overall amount of HilD/HilC/RtsA in the cell, given the ectopic HilD expression will induce the native loci with autoinduction intact. Your data seem clear and induction of hilA also confers the phenotype. However, you should likely acknowledge this caveat.

9. Line 264. What is the evidence that “translation rate” per se is affected? The word “translation” is not used in Ref 53.

10. Figure 6. How long were these cells induced? Does time matter?

11. Although your model is intriguing, it goes against the apparent coordinate transcriptional induction of the two systems. Why would HilD turn on FlhDC if the goal is to stop swimming? You need to at least comment on this. I am wondering if the timing of these events matters and perhaps needs more careful explanation and consideration. The materials and methods implies that the cells in Fig 6 were incubated for 5 mins? Fig 1 suggests that loss of motility occurs after 45 mins?

Reviewer #3: 1. The number of biological replicates should be indicated for each experiment.

2. In the proposed model, would the reversibility of the commitment to attachment (e.g., in case of failed interactions with the host cell) be an advantage of the mechanism proposed in the authors’ model over the ejection of flagella?

3. Line 91, ref. 29 does not deal with injectisomes, please add suitable reference.

4. Line 98, please describe how FliZ regulates HilD in ref. 34.

5. Line 110, in contrast to the claim that “HilD activates the expression of SPI-2 genes”, ref. 43 explicitly states (in the abstract) that “HilD is not required for SPI-2 regulon expression under the in vitro growth conditions that are thought to resemble the intracellular environment”.

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example see here on PLOS Biology: http://www.plosbiology.org/article/info:doi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Revision 1

Attachments
Attachment
Submitted filename: Response to reviewers.docx
Decision Letter - Nina R. Salama, Editor, Sophie Helaine, Editor

Dear Ms. Saleh,

We are pleased to inform you that your manuscript 'SPI-1 virulence gene expression modulates motility of Salmonella Typhimurium in a proton motive force- and adhesins-dependent manner' has been provisionally accepted for publication in PLOS Pathogens.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Sophie Helaine

Academic Editor

PLOS Pathogens

Nina Salama

Section Editor

PLOS Pathogens

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

***********************************************************

Reviewer Comments (if any, and for reference):

Formally Accepted
Acceptance Letter - Nina R. Salama, Editor, Sophie Helaine, Editor

Dear Ms. Saleh,

We are delighted to inform you that your manuscript, "SPI-1 virulence gene expression modulates motility of Salmonella Typhimurium in a proton motive force- and adhesins-dependent manner," has been formally accepted for publication in PLOS Pathogens.

We have now passed your article onto the PLOS Production Department who will complete the rest of the pre-publication process. All authors will receive a confirmation email upon publication.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any scientific or type-setting errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript. Note: Proofs for Front Matter articles (Pearls, Reviews, Opinions, etc...) are generated on a different schedule and may not be made available as quickly.

Soon after your final files are uploaded, the early version of your manuscript, if you opted to have an early version of your article, will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Pathogens.

Best regards,

Kasturi Haldar

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0001-5065-158X

Michael Malim

Editor-in-Chief

PLOS Pathogens

orcid.org/0000-0002-7699-2064

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .